124
Participants
Start Date
December 31, 2011
Primary Completion Date
November 30, 2015
Study Completion Date
November 30, 2015
Varenicline
Varenicline will be prescribed to non-abstinent smokers at the same doses as have been demonstrated to be clinically effective: 0.5 mg twice a day for 3 days and then 1mg twice daily for the remainder of the treatment course of 8 weeks.
Placebo
Placebo will be prescribed to non-abstinent smokers at the same doses as have been demonstrated to be clinically effective for Varenicline: 0.5 mg twice a day for 3 days and then 1mg twice daily for the remainder of the treatment course of 8 weeks.
University of Pennsylvania Addiction Treatment Research Center, Philadelphia
National Institute on Drug Abuse (NIDA)
NIH
National Institutes of Health (NIH)
NIH
University of Pennsylvania
OTHER